Fig_3.tif (477.35 kB)
Association between fibrosis progression rate and combining risk analysis (FPR score).
figure
posted on 2015-09-09, 04:34 authored by Nobuharu Tamaki, Masayuki Kurosaki, Mayu Higuchi, Hitomi Takada, Natsuko Nakakuki, Yutaka Yasui, Shoko Suzuki, Kaoru Tsuchiya, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Shintaro Ogawa, Yasuhito Tanaka, Yasuhiro Asahina, Namiki IzumiIL28B TG/GG, PNPLA3 CG/GG, and average ALT after interferon therapy ≥ 40 IU/l were scored as 1 point. Similarly, IL28B TT, PNPLA3 CC, and average ALT after interferon therapy < 40 IU/l were scored as 0 point. Patients scored 0–1, 2 and 3 were defined as a low, intermediate, and high risk group, respectively. Error bars indicate the standard error.
